Antithrombotic stewardship: whether to stop anticoagulation after atrial fibrillation ablation

Lorenz Roger Van der Linden1,2, Qi Shao2, Laura Hellemans3,2

  • 1Hospital Pharmacy Department, University Hospitals Leuven, Leuven, Belgium lorenz.vanderlinden@uzleuven.be.

Insights

Oral anticoagulation (OAC) may not be necessary for select atrial fibrillation (AF) patients after ablation. Recent trials suggest low stroke risk, but limitations exist, requiring careful patient selection before OAC discontinuation.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Growing questions regarding oral anticoagulation (OAC) discontinuation in atrial fibrillation (AF) patients post-ablation.
  • Recent trials (ALONE-AF, OCEAN) indicate low stroke rates in selected arrhythmia-free AF patients after ablation.

Purpose of the Study:

  • To evaluate the necessity of OAC in AF patients who are arrhythmia-free post-ablation.
  • To analyze the findings and limitations of recent trials on OAC discontinuation in this cohort.

Main Methods:

  • Review of recent clinical trials (ALONE-AF, OCEAN) investigating OAC use in post-ablation AF patients.
  • Critical analysis of study methodologies, patient selection criteria, and statistical power for thromboembolic events.

Main Results:

  • Selected post-ablation AF patient cohorts showed low annual stroke rates in recent trials.
  • These trials suggest potentially limited added stroke protection from OAC in this specific group.

Conclusions:

  • OAC discontinuation may be considered in carefully selected AF patients post-ablation.
  • Key criteria include 12-month arrhythmia-free status, low thromboembolic risk, no prior stroke, and intensified monitoring, though validated strategies are lacking.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Amyloid Fibrils03:03

Amyloid Fibrils

6.5K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
625